UCB's Global Corporate Website
Welcome to UCB in the United States
  • Healthcare Professionals
  • Patients
  • Investors
  • Newsroom

    Spotlight Story

    UCB’s Kassandra Watson and Windy Wang Recognized by Healthcare Businesswomen’s Association (HBA) as Luminary and Rising Star

    Read more

    Press Releases

    UCB presents latest research across leading neurology portfolio at American Academy of Neurology (…

    Read More

    New data on investigational therapy for thymidine kinase 2 deficiency presented at Muscular…

    Read More

    Epilepsia Publishes Final Analysis of Open-Label Extension Study of Long-Term Safety and…

    Read More

    BIMZELX® (bimekizumab-bkzx) Two-Year Data at AAD Showed Potential to Eliminate Draining Tunnels in…

    Read More

    BIMZELX® (bimekizumab-bkzx) Five-Year Data at AAD 2025 Showed Sustained Skin Clearance and Long-…

    Read More

    On Growth Path for a Decade plus: Strong Launch Execution driving Company Growth

    Read More

    UCB Stories

    Resources for Resilience: Dravet Syndrome Awareness Month for Families Living with DEEs

    Read More

    Partnering with Patient Communities to Advance HS Awareness and Care

    Read More

    Recognizing Myasthenia Gravis Month – The Importance of Addressing Unmet Patient Needs

    Read More

    Earth Day 2025: Advancing Our Commitment to a Healthier Planet

    Read More

    The First UCB US Rare Disease Connect in Neurology (RDCN) Annual Summit Launches at American…

    Read More

    Join UCB at the MGFA National Patient Conference and Visit Our Experience Room

    Read More

    For More Information

    OSZAR »